Comparative study of glycemic control and treatment satisfaction for patients with type 1 diabetes on sensor augmented insulin pump, insulin pump and multiple daily insulin injection: cross sectional study
Автор: Alshahrani A.A., Almutairi F.S.
Журнал: Cardiometry @cardiometry
Рубрика: Original research
Статья в выпуске: 30, 2024 года.
Бесплатный доступ
BACKGROUND: All patients with T1DM are on life-long insulin injection . However, since last decades with evolving diabetes technology ,there is a paucity of research on glycemic and self satisfaction effectiveness of new insulin pump and CGM devices in Saudi Arabia population whom they have different lifestyle and race. PATIENTS AND METHODS: A cross-sectional study was con-ducted at King Abdulaziz Medical City Endocrine Center in Ri-yadh, Saudi Arabia. The study focused on a sample of patients with type 1 diabetes aged 14 years and above using either a sensor-augmented insulin pump (Medtronic MiniMed 640G, 740G), insulin pump without a sensor (Medtronic Paradigm VEO 754), or multiple daily insulin injections for at least 6 months.
Type 1 diabetes, insulin pump, multiple daily insulin, satisfaction, glycemic control
Короткий адрес: https://sciup.org/148328271
IDR: 148328271 | DOI: 10.18137/cardiometry.2024.30.6272
Список литературы Comparative study of glycemic control and treatment satisfaction for patients with type 1 diabetes on sensor augmented insulin pump, insulin pump and multiple daily insulin injection: cross sectional study
- Katsarou A, Gudbjornsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. Type 1 diabetesmellitus. Nature Reviews Disease Primers. 2017;3: 17016.
- Robert AA, Al-Dawish A, Mujammami M, Dawish MAA. Type 1 diabetesmellitus in Saudi Arabia: A SoaringEpidemic. Int J Pediatr. 2018May 8; 9408370. doi:10.1155/2018/9408370.
- Bullock AK,Shef K. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. The New England Journal of Medicine 2017; 377( 3): 301.
- Omoy MN, Ngoy DM, Ilunga EK, Ntumba DB, Wakamb GKA, Okitosho SW, et al. Type 1 diabetesmellitus in children less than 5 years: case study conducted at the university clinics of lubumbashi and review of the literature. Pan AfricanMedical Journal 2017; 26: 170.
- van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiological Reviews 2011; 91(1):79–118.
- Arffman M, Hakkarainen P, Keskimäki I, Oksanen T, Sund R. Long-term and recent trends in survival and life expectancy for people with type 1 diabetes in Finland. DiabetesRes Clin Pract. 2023 Apr;198:110580. doi: 10.1016/j.diabres.2023.110580. Epub 2023 Feb 18. PMID: 36804193.
- Buse JB, Kudva YC, Battelino T, Davis SN, Shin J, Welsh JB. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technology &Therapeutics 2012;14(7):644-647. DOI: 10.1089/dia.2011.0294.
- Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med2010;363:311–320.
- Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuationphase. Diabetes Care 2011;34:2403–2405.
- Zhong A, Choudhary P, McMahon C, Agrawal P, Welsh JB, Cordero TL, et al. Effectiveness of automated insulin management features of the MiniMedc640G sensor-augmentedinsulin pump. Diabetes Technology&therapeutics 2016;18(10): 657-663. DOI: 10.1089/dia.2016.0216.
- Wilbur K. Diabetes Treatment Satisfaction Questionnaire Arabic adaptation for Qatar. Diabetes Res ClinPract. 2013;99(2):e24–6. doi:10.1016/j.diabres.2012.11.007.
- Moser EG, Morris AA, Garg SK. Emerging diabetes therapies and technologies. Diabetes Res Clin Pract.2012;97:16-26.doi: 10.1016/j.diabres.2012.01.027.
- Nicolucci A, Maione A, Franciosi M, AmorettiR, BusettoE,CapaniF,et al. Quality of life and treatment satisfaction in adults with Type 1diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections. DiabetMed. 2008;25:213-20.doi: 10.1111/j.1464-5491.2007.02346.x.
- Al Hayek AA, Robert AA, Al Dawish MA, Braham- RB,.Goudeh HS. Al Sabaan FS. Efficacy of insulin pump therapy on diabetes treatment satisfaction and glycemic control among patients with type 1 diabetes mellitus in Saudi Arabia: A prospective study. DiabetesTher 2015; 6:227–236. doi:10.1007/s13300-015-0107-1.
- Hermanides J, Nørgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan CM, et al. Sensor-augmented pump therapy lowersHbA(1c) in suboptimallycontrolledType 1 diabetes; a randomizedcontrolled trial. DiabetMed. 2011 Oct;28(10):1158-67. doi: 10.1111/j.1464-5491.2011.03256.x.
- Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010 Jul 22;363(4):311-20. doi: 10.1056/NEJMoa1002853.
- Hussain T, Akle M, Nagelkerke N, Deeb A. Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetesmellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy. SAGE Open Medicine 2017;5:1-6. Doi: 10.1177/2050312117694938
- Pickup JC. Insulin-pump therapy for type 1 diabetes mellitus.N Engl J Med 2012; 366: 1616–1624.doi: 10.1056/NEJMct1113948.
- Battaglia MR, Alemzadeh R, Katte H, Hall PL, Perlmuter LC. Brief report: disordered eating and psychosocial factors in adolescent females with type 1 diabetes mellitus. J PediatrPsychol 2006; 31:552-556.doi: 10.1093/jpepsy/jsj047.
- Hirose M, Beverly EA, Weinger K. Quality of life and technology: impact on children and families with diabetes.Curr Diab Rep 2012; 12(6): 711-720.doi: 10.1007/s11892-012-0313-4.
- Low KG, Massa L, Lehman D, Olshan JS. Insulin pump use inyoungadolescents with type 1 diabetes: a descriptive study.PediatrDiabetes 2005; 6: 22–31. doi: 10.1111/j.1399-543X.2005.00089.x.
- Nicolucci A, Cucinotta D, Squatrito S, Lapolla A, Musacchio N, Leotta S, et al. Clinicaland socio-economic correlates of quality of life and treatment satisfaction in patients with type 2diabetes. NutrMetab Cardiovasc Dis. 2009; 19: 45–53. doi: 10.1016/j.numecd. 2007.12.005.
- Ritholz MD, Smaldone A, Lee J, Castillo A, Wolpert H, Weinger K. Perceptions of psychosocial factors and the insulin pump. Diabetes Care. 2007; 30: 549-54. doi: 10.2337/dc06-1755.
Статья научная
